Development and Application of Virtual Reality (VR) and Human Computer Interaction System in the ICU Patients

August 30, 2022 updated by: Shanghai Zhongshan Hospital

Virtual Reality (VR) and Human Computer Interaction System in the Early Stage of ICU Patients Development and Application of Rehabilitation Exercise

By developing of VR and human computer interaction system of early rehabilitation exercise for ICU patients, this project aims to construct virtual scenes and realize the interaction between ICU patients and virtual scenes during active rehabilitation training for critically ill patients in long-term bed. This project can increase the patient's willingness to exercise rehabilitation, improve the training effect and improve clinical outcomes in critically ill patients.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

244

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Shanghai, China, 200032
        • Recruiting
        • 180 Fenglin Road
        • Contact:
          • Wenyan PAN

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

  • Inclusion Criteria:

    • Over 18 years of age
    • Voluntary participation
  • Exclusion Criteria:

    • Unable to walk independently before admission to ICU;
    • High dose of vasoactive drugs to maintain vital signs;
    • Acute stroke;
    • Upper limb fractures or amputations;
    • Patients with spinal fracture or pathological fracture;
    • Patients who have been hospitalized for 30 days or more before admission to ICU;
    • Plan to move out of ICU within 24 hours; In palliative care

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
Experimental: intervention group
The experimental group used VR technology and human-computer interaction system for exercise, while the control group used traditional exercise program

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of the ICU-acquired asthenia
Time Frame: up to 2 weeks
during ICU stay
up to 2 weeks
Average daily physical activity time
Time Frame: up to 2 weeks
during ICU stay
up to 2 weeks
length of ICU stay
Time Frame: up to 2 weeks
during ICU stay
up to 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wenyan PAN, Fudan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2021

Primary Completion (Anticipated)

September 1, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

November 30, 2021

First Submitted That Met QC Criteria

August 30, 2022

First Posted (Actual)

August 31, 2022

Study Record Updates

Last Update Posted (Actual)

August 31, 2022

Last Update Submitted That Met QC Criteria

August 30, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2020ZSLC68

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation Exercise of ICU Patients

Clinical Trials on Virtual Reality (VR) and human computer interaction system

3
Subscribe